Defining Real-World Economic Factors
In development of innovative, disruptive and new medical technologies, defining real world economic factors is a crucial step to succeeding in commercial adoption. Synthetic and traditional health economic modeling typically are limited by purchasing available data. By leveraging established public data sources, innovative medtech can precisely measure economic impact.
Early Stage Economic Integration
In coordination with ideation, R&D, regulatory and FDA trials, economic studies are optimal from early stages of development.
Stakeholder-Aligned Analysis
Among a diverse set of stakeholders—government, payer, provider and specialty society—each value specific assessments of economic impact.
Technology & Payment Translation
For established devices and technology, identify key clinical/technological factors and how they translate to payment. These issues may impact physician and facility adoption—we can tell you why.
Utilization: The True Cost of Care
Utilization: Identify every clinical/economic milepost found in patient presentation, diagnosis, treatment and follow up. Includes all costs, with stand alone and or bundled payments. How much does it really cost? Translation to reimbursement in all settings (inpatient, OP surgery, office, emergency room).
This critical information is not available in purchased data files.
Why Choose Us
We provide comprehensive reimbursement assessments, including coding, coverage, and payment strategies for both inpatient and outpatient settings. Our team supports microeconomic studies during clinical trials and commercialization phases, offering detailed comparisons to traditional procedures. Additionally, we assist with CMS Investigational Device Exemption (IDE) applications and offer guidance on clinical trial reimbursement to ensure optimal market access.